From: Recent advances in delivery of veterinary DNA vaccines against avian pathogens
Pathogens | Host/day of vaccination | Vehicle | Target antigen/adjuvant | Route of vaccination | Immune responses | Protection | Ref. |
---|---|---|---|---|---|---|---|
AIV | Chicken/3 and 6 week | Naked plasmid | H6 + Kozak sequence | IM | Anti-HA Ab | Not tested | [32] |
AIV | Chicken/10, 24 and 38 day | Naked plasmid | H5 and HSP-70 | IM | Anti-HA Ab | Not tested | [13] |
AIV | Chicken/7, 21 and 35 day | Naked plasmid | H5 and Esat-6 | IM | Anti-HA Ab | Not tested | [10] |
AIV | Chicken/1 and 14 day | Naked plasmid | N1 and IL15 | IM | Anti-N1 Ab/CD4 and CD8 | Not tested | [9] |
ILTV | Chicken/3 and 5 week | Naked plasmid | gB and IL18 | IM | Anti-ILTV Ab and CD4 and CD8 | 80% | [84] |
IBV | Chicken/7, 21 and 35 day | Naked plasmid | S1, N, and M | IM | IBV-neutralizing Ab and CD4/CD8 | 90% | [85] |
NDV | Chicken/21, 36 and 46 day | Naked plasmid | HN, F, and IL4 | IM | Anti-NDV Ab and cellular immune responses | 40% | [34] |
AIV | Chicken/3, 7 and 11 week | Naked plasmid + liposome | H5 | IM | Anti-HA Ab | Not tested | [27] |
AIV | Chicken/3 and 6 week | pHEMA | H6 | IM | Ab response | Reduced virus shedding | [86] |
C. psittaci | Turkey/1 and 3 week | Branched PEI | OmpA | IM | IgG and increased CD4/CD8 rate response | Reduced C. psittaci shedding and shortened the period of clinical signs | [77] |
Anatid herpesvirus 1 | Duck/4 week | Chitosan and liposome | gC | IM | Rapid and extensive plasmid distribution in duck tissues | Not tested | [87] |
NDV | Chicken/1 week | Lipofectin | F and HN | IM | Anti-F Ab | 80% | [88] |
Coccidiosis | Chicken/1 and 2 week | Naked plasmid | Gam56 from Eimeria maxima | IM | Ab and lymphocyte proliferation | No chicken died from E. tenella challenge in any group | [89] |
IBDV | Chicken/2 and 4 week | Naked plasmid | VP2 + HSP70 | IM | Anti-VP2 Ab and lymphocyte proliferation | 100% | [14] |
CIA | Chicken/3, 5 and 7 week | Naked plasmid | VP1 and VP2 + HMGB1ΔC | IM | Anti-CIA Ab and CD8 | Not tested | [12] |
NDV | Chicken/30 and 44 day | Chitosan nanoparticles | F | IM/IN | IgA/IgG and lymphocyte proliferation | IM: 80% IN: 100% | [90] |
REV | Chicken/3 and 6 week | Naked plasmid | gp90 + WPRE | IM | Lymphocyte proliferation, Ab response and IL-4 and IFN-γ | 87% | [91] |
P. multocida | Chicken/4, 6 and 8 week | Naked plasmid | OmpH and OmpA | IM | Induction of CD8 T cells, high serum Ab titres, and IFN-γ | 70% | [92] |
Coccidiosis | Chicken/2 and 3 week | Naked plasmid | TA4 and chicken IL-2 | IM | Humoral response | ~80% | [93] |
Anatid herpesvirus 1 | Duck/4 week | Naked plasmid + chitosan DNA and liposome | gC | IM | Extensive plasmid distribution in duck tissues | Not tested | [87] |
DEV | Duck/10 and 12 week | Naked plasmid | gD and B | IM | Stimulated a high frequency of CD4, CD8 T cells and neutralizing antibody | 70% | [94] |
TCoV | Turkey/1, 7 and 21 day | Naked plasmid +PEI and sodium hyaluronate | 4F/4R | IM | Anti-TCoV S Ab and VN titre | Decrease in clinical signs from 5/5 to 1/5 or 2/5 | [95] |
Coccidiosis | Chicken/4, 14 and 21 day | Naked plasmid | EtMIC2 + IL-18 | IM | Anti-EtMic2 Ab, CD8/CD4 T cells | No chicken died from E. tenella challenge in any group | [96] |
AIV | Quail/3, 6 and 9 week | Naked plasmid | H5 | IM | Anti-HA Ab | 100% | [21] |
NDV | Chicken/30 and 44 day | Nano-chitosan | F | IM/IN | IgG and IgA and lymphocyte proliferation | 80% (IM); 100% (IN) | [26] |
IBDV | Egg embryonation on day 18 and at 1 week | Naked plasmid/killed vaccine | VP2, VP3, VP4 + killed virus booster | IO/IM | Anti-IBDV Ab and lymphocyte proliferation | 100% | [43] |
DPV | Duck/3 week | Naked plasmid +gold particles | gC | IM + GG | Increase the numbers of CD4, CD8 T cells and neutralizing antibody | Not tested | [97] |
AVA | Chicken/6 and 13 day | S. typhimurium SL7207 | pVAX-rC | Oral | Ab response | 66.7% | [66] |
AIV | Chicken/2 and 4 week | S. typhimurium SL7207 | H1 | Oral | Anti-HA intestinal mucosal IgA response and lymphoproliferation | 100% (combined with killed vaccine) | [65] |
Coccidiosis | Chicken/3 and 17 day | S. typhimurium SV4089 | 5401 | Oral | Ab and cellular immune responses | 55–57.5% | [62] |
IBDV | Chicken/7 and 12 day | S. typhimurium SV4089 | VP2/4/3 | Oral | Ab response | 73.3% | [61] |
AIV | Chicken/1 day | S. typhimurium SV4089 | H1 | Oral | Anti-HA Ab and CD4/CD8 T cells | Not tested | [19] |
CAV | Chicken/2, 4 and 6 week | L. acidophilus | VP1 | Oral | Anti-CAV Ab/cell mediated responses | Not tested | [71] |
IBDV | Chicken/7 and 14 day | Transgenic E. coli DH5α | VP2 | Oral | Anti-IBDV Ab | 95.4% | [54] |
AIV | Chicken/1 day | NanoAg-poly(ethylene glycol) | H5 | Oral | Anti-HA Ab and CD4/CD8 T cell response | Not tested | [20] |
AIV | Chicken/10 and 24 day | Lactobacillus (LDL17-pH) | H1 | Oral | Anti-HA mucosal IgA and serum IgG l, IFNγ, TLR-2, and AvBD-9 in the PPs and CTs | 60% | [72] |
DEV | Duck/3 times per day for 7 day | S. typhimurium | UL24Â +Â labile enterotoxin B subunit | Oral | Serum IgA and IgG, DEV-specific mucosal IgA and anti-NA Ab | 60-80% | [67] |
DTMUV | Duck/8 and 24 day | S. typhimurium SL7207 | prM and E | Oral | Specific antibody against the E protein and VN | 100% | [68] |
IBDV | Chicken/2 and 16 day | S. enterica serovar Typhimurium | S1 and N | Oral/IN | Humoral and mucosal immune responses | 70% | [25] |
C. jejuni | Chicken/1, 15 and 29 day | Nano-chitosan | Protein FlaA | IN | IgG and intestinal mucosa IgA responses | Not tested | [79] |
M. gallisepticum | Chicken/2 week | M. gallisepticum ts-11 | ts-11 C3 and IFN-γ | ED | Cell-mediated immunity | Not tested | [98] |
IBDV | Chicken/3, 5 and 7 week | PLGA | VP2 | ED | Stimulation of CD4 and CD8 T cells, high level of IgG | 80% | [78] |
AIV | Chicken/1 and 28 day | Naked plasmid | H7 | IV, IP, and SC | Anti-HA Ab | 50% | [99] |
AIV | Chicken/3 week | Naked plasmid | H5 | GG | Anti-HA Ab | 100% | [16] |
AIV | Duck/5 and 8 week | Naked plasmid | H5 | External thigh muscle, Medi Jector Vision | NV Ab | Not tested | [100] |
NDV and IBDV | Egg embryonation at 14–18 day | Plasmid/neutral lipid/DMSO | HA, VP2, VP4 and VP3 | IO | Expression of viral protein | Not tested | [36] |
NDV | Egg embryonation at 18 day | Naked plasmid | F and HN | IO | Anti-HA Ab | 28% | [42] |
IBV | Egg embryonation at 18 day | Naked plasmid/IFNα | gS | IO | Humoral immune responses | 89% | [101] |
ILTV | Egg embryonation at 18 day | Naked plasmid | CpG | IO | IgM, KUL01, and CD8 and CD4 cells | ~40% | [41] |